Li M Fu
Despite decades of intensive research, the pathogenesis of neurodegenerative disorders, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), is still not fully understood. Latest genomics technology offers a new perspective on this issue. Yet, the genomics-based approach to pathogenesis identification is a new technology at the incipient stage. In this communication, we summarize the current progress along this line and report the commonality and difference in pathogenesis between AD and PD revealed by this approach.
